Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction

Merry L. Lindsey, G. Patricia Escobar, Lawrence W. Dobrucki, Danielle K. Goshorn, Shenikqua Bouges, Joseph T. Mingoia, David M. McClister, Haili Su, Joseph Gannon, Catherine MacGillivray, Richard T. Lee, Albert J. Sinusas, Francis G. Spinale

Research output: Contribution to journalArticle

147 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) are postulated to be necessary for neovascularization during wound healing. MMP-9 deletion alters remodeling postmyocardial infarction (post-MI), but whether and to what degree MMP-9 affects neovascularization post-MI is unknown. Neovascularization was evaluated in wild-type (WT; n = 63) and MMP-9 null (n = 55) mice at 7-days post-MI. Despite similar infarct sizes, MMP-9 deletion improved left ventricular function as evaluated by hemodynamic analysis. Blood vessel quantity and quality were evaluated by three independent studies. First, vessel density was increased in the infarct of MMP-9 null mice compared with WT, as quantified by Griffonia (Bandeiraea) simplicifolia lectin I (GSL-I) immunohistochemistry. Second, preexisting vessels, stained in vivo with FITC-labeled GSL-I pre-MI, were present in the viable but not MI region. Third, a technetium-99m-labeled peptide (NC100692), which selectively binds to activated α v β 3 -integrin in angiogenic vessels, was injected into post-MI mice. Relative NC100692 activity in myocardial segments with diminished perfusion (0-40% nonischemic) was higher in MMP-9 null than in WT mice (383 ± 162% vs. 250 ± 118%, respectively; P = 0.002). The unique finding of this study was that MMP-9 deletion stimulated, rather than impaired, neovascularization in remodeling myocardium. Thus targeted strategies to inhibit MMP-9 early post-MI will likely not impair the angiogenic response.

Original languageEnglish (US)
Pages (from-to)H232-H239
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume290
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Matrix Metalloproteinase 9
Gene Deletion
Myocardial Infarction
Infarction
Fluorescein-5-isothiocyanate
Technetium
Matrix Metalloproteinases
Left Ventricular Function
Integrins
Wound Healing
Blood Vessels
Myocardium
Perfusion
Hemodynamics
Immunohistochemistry
Peptides

Keywords

  • Imaging
  • Leukocytes
  • Remodeling

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. / Lindsey, Merry L.; Escobar, G. Patricia; Dobrucki, Lawrence W.; Goshorn, Danielle K.; Bouges, Shenikqua; Mingoia, Joseph T.; McClister, David M.; Su, Haili; Gannon, Joseph; MacGillivray, Catherine; Lee, Richard T.; Sinusas, Albert J.; Spinale, Francis G.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 290, No. 1, 01.01.2006, p. H232-H239.

Research output: Contribution to journalArticle

Lindsey, ML, Escobar, GP, Dobrucki, LW, Goshorn, DK, Bouges, S, Mingoia, JT, McClister, DM, Su, H, Gannon, J, MacGillivray, C, Lee, RT, Sinusas, AJ & Spinale, FG 2006, 'Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction', American Journal of Physiology - Heart and Circulatory Physiology, vol. 290, no. 1, pp. H232-H239. https://doi.org/10.1152/ajpheart.00457.2005
Lindsey, Merry L. ; Escobar, G. Patricia ; Dobrucki, Lawrence W. ; Goshorn, Danielle K. ; Bouges, Shenikqua ; Mingoia, Joseph T. ; McClister, David M. ; Su, Haili ; Gannon, Joseph ; MacGillivray, Catherine ; Lee, Richard T. ; Sinusas, Albert J. ; Spinale, Francis G. / Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. In: American Journal of Physiology - Heart and Circulatory Physiology. 2006 ; Vol. 290, No. 1. pp. H232-H239.
@article{6cb0580e7801454ab1905db3647aa51a,
title = "Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction",
abstract = "Matrix metalloproteinases (MMPs) are postulated to be necessary for neovascularization during wound healing. MMP-9 deletion alters remodeling postmyocardial infarction (post-MI), but whether and to what degree MMP-9 affects neovascularization post-MI is unknown. Neovascularization was evaluated in wild-type (WT; n = 63) and MMP-9 null (n = 55) mice at 7-days post-MI. Despite similar infarct sizes, MMP-9 deletion improved left ventricular function as evaluated by hemodynamic analysis. Blood vessel quantity and quality were evaluated by three independent studies. First, vessel density was increased in the infarct of MMP-9 null mice compared with WT, as quantified by Griffonia (Bandeiraea) simplicifolia lectin I (GSL-I) immunohistochemistry. Second, preexisting vessels, stained in vivo with FITC-labeled GSL-I pre-MI, were present in the viable but not MI region. Third, a technetium-99m-labeled peptide (NC100692), which selectively binds to activated α v β 3 -integrin in angiogenic vessels, was injected into post-MI mice. Relative NC100692 activity in myocardial segments with diminished perfusion (0-40{\%} nonischemic) was higher in MMP-9 null than in WT mice (383 ± 162{\%} vs. 250 ± 118{\%}, respectively; P = 0.002). The unique finding of this study was that MMP-9 deletion stimulated, rather than impaired, neovascularization in remodeling myocardium. Thus targeted strategies to inhibit MMP-9 early post-MI will likely not impair the angiogenic response.",
keywords = "Imaging, Leukocytes, Remodeling",
author = "Lindsey, {Merry L.} and Escobar, {G. Patricia} and Dobrucki, {Lawrence W.} and Goshorn, {Danielle K.} and Shenikqua Bouges and Mingoia, {Joseph T.} and McClister, {David M.} and Haili Su and Joseph Gannon and Catherine MacGillivray and Lee, {Richard T.} and Sinusas, {Albert J.} and Spinale, {Francis G.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1152/ajpheart.00457.2005",
language = "English (US)",
volume = "290",
pages = "H232--H239",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction

AU - Lindsey, Merry L.

AU - Escobar, G. Patricia

AU - Dobrucki, Lawrence W.

AU - Goshorn, Danielle K.

AU - Bouges, Shenikqua

AU - Mingoia, Joseph T.

AU - McClister, David M.

AU - Su, Haili

AU - Gannon, Joseph

AU - MacGillivray, Catherine

AU - Lee, Richard T.

AU - Sinusas, Albert J.

AU - Spinale, Francis G.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Matrix metalloproteinases (MMPs) are postulated to be necessary for neovascularization during wound healing. MMP-9 deletion alters remodeling postmyocardial infarction (post-MI), but whether and to what degree MMP-9 affects neovascularization post-MI is unknown. Neovascularization was evaluated in wild-type (WT; n = 63) and MMP-9 null (n = 55) mice at 7-days post-MI. Despite similar infarct sizes, MMP-9 deletion improved left ventricular function as evaluated by hemodynamic analysis. Blood vessel quantity and quality were evaluated by three independent studies. First, vessel density was increased in the infarct of MMP-9 null mice compared with WT, as quantified by Griffonia (Bandeiraea) simplicifolia lectin I (GSL-I) immunohistochemistry. Second, preexisting vessels, stained in vivo with FITC-labeled GSL-I pre-MI, were present in the viable but not MI region. Third, a technetium-99m-labeled peptide (NC100692), which selectively binds to activated α v β 3 -integrin in angiogenic vessels, was injected into post-MI mice. Relative NC100692 activity in myocardial segments with diminished perfusion (0-40% nonischemic) was higher in MMP-9 null than in WT mice (383 ± 162% vs. 250 ± 118%, respectively; P = 0.002). The unique finding of this study was that MMP-9 deletion stimulated, rather than impaired, neovascularization in remodeling myocardium. Thus targeted strategies to inhibit MMP-9 early post-MI will likely not impair the angiogenic response.

AB - Matrix metalloproteinases (MMPs) are postulated to be necessary for neovascularization during wound healing. MMP-9 deletion alters remodeling postmyocardial infarction (post-MI), but whether and to what degree MMP-9 affects neovascularization post-MI is unknown. Neovascularization was evaluated in wild-type (WT; n = 63) and MMP-9 null (n = 55) mice at 7-days post-MI. Despite similar infarct sizes, MMP-9 deletion improved left ventricular function as evaluated by hemodynamic analysis. Blood vessel quantity and quality were evaluated by three independent studies. First, vessel density was increased in the infarct of MMP-9 null mice compared with WT, as quantified by Griffonia (Bandeiraea) simplicifolia lectin I (GSL-I) immunohistochemistry. Second, preexisting vessels, stained in vivo with FITC-labeled GSL-I pre-MI, were present in the viable but not MI region. Third, a technetium-99m-labeled peptide (NC100692), which selectively binds to activated α v β 3 -integrin in angiogenic vessels, was injected into post-MI mice. Relative NC100692 activity in myocardial segments with diminished perfusion (0-40% nonischemic) was higher in MMP-9 null than in WT mice (383 ± 162% vs. 250 ± 118%, respectively; P = 0.002). The unique finding of this study was that MMP-9 deletion stimulated, rather than impaired, neovascularization in remodeling myocardium. Thus targeted strategies to inhibit MMP-9 early post-MI will likely not impair the angiogenic response.

KW - Imaging

KW - Leukocytes

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=33644810862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644810862&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00457.2005

DO - 10.1152/ajpheart.00457.2005

M3 - Article

C2 - 16126817

AN - SCOPUS:33644810862

VL - 290

SP - H232-H239

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1

ER -